PAKs inhibitors ameliorate schizophrenia-associated dendritic spine deterioration in vitro and in vivo during late adolescence.
about
Non-muscle myosin II in disease: mechanisms and therapeutic opportunitiesStress weakens prefrontal networks: molecular insults to higher cognitionTargeting Prefrontal Cortical Systems for Drug Development: Potential Therapies for Cognitive DisordersP21-Activated Kinase Inhibitors FRAX486 and IPA3: Inhibition of Prostate Stromal Cell Growth and Effects on Smooth Muscle Contraction in the Human ProstateMolecular substrates of schizophrenia: homeostatic signaling to connectivityPyramidal Neurons in Different Cortical Layers Exhibit Distinct Dynamics and Plasticity of Apical Dendritic Spines.Altered expression of CDC42 signaling pathway components in cortical layer 3 pyramidal cells in schizophrenia.Abnormalities in synaptic dynamics during development in a mouse model of spinocerebellar ataxia type 1.Labelling and optical erasure of synaptic memory traces in the motor cortex.Converging models of schizophrenia--Network alterations of prefrontal cortex underlying cognitive impairments.Utility and validity of DISC1 mouse models in biological psychiatry.Disturbance in Maternal Environment Leads to Abnormal Synaptic Instability during Neuronal Circuitry DevelopmentEmerging Synaptic Molecules as Candidates in the Etiology of Neurological Disorders.Myosin IIA-related Actomyosin Contractility Mediates Oxidative Stress-induced Neuronal ApoptosisNovel treatment strategies for schizophrenia from improved understanding of genetic risk.Altering the course of schizophrenia: progress and perspectives.Optogenetics: Applications in psychiatric research.Role of DISC1 in Neuronal Trafficking and its Implication in Neuropsychiatric Manifestation and Neurotherapeutics.Neurexin-Neuroligin Synaptic Complex Regulates Schizophrenia-Related DISC1/Kal-7/Rac1 "Signalosome".The potential of DISC1 protein as a therapeutic target for mental illness.Sequence of Molecular Events during the Maturation of the Developing Mouse Prefrontal Cortex.GIT1 and βPIX are essential for GABA(A) receptor synaptic stability and inhibitory neurotransmission.MHCI promotes developmental synapse elimination and aging-related synapse loss at the vertebrate neuromuscular junction.Engineering Pak1 Allosteric Switches.Aberrant Rac1-cofilin signaling mediates defects in dendritic spines, synaptic function, and sensory perception in fragile X syndrome.PAK1 regulates inhibitory synaptic function via a novel mechanism mediated by endocannabinoids.Synaptic loss in schizophrenia: a meta-analysis and systematic review of synaptic protein and mRNA measures.Combined inhibition of receptor tyrosine and p21-activated kinases as a therapeutic strategy in childhood ALL
P2860
Q26778962-B3530123-2F6D-4AA6-B0BB-BBEC789B1E15Q26781227-F94F4A33-CE09-4956-9B6A-E70A4570E59FQ28076907-BF4F3587-C252-44FB-914C-9B653F96B757Q28551296-E3F6A571-5EF0-49B4-AC41-8CE8AA033A44Q30383611-B80EA35F-73A4-49FF-B567-245CA4830168Q33809538-40ACDD48-37CC-4583-8911-BD4AAE55C5F3Q35633518-16C486A3-CD25-4657-A032-FC8DADA0FAFAQ36245783-233BF3D5-E984-4BA2-BFF5-3EC77C560F95Q36252727-49CE43DD-E4E7-4F81-A660-BD64FE9250CEQ36307544-9D477EE2-AC0E-4CAC-96E2-5BBB74B7B3E4Q36717234-2D705018-E63C-4179-B061-391727BDB16FQ37625505-B194F361-D407-4D5C-BAB0-15427B32BDCEQ37694175-83AD4861-4404-4DC8-AFB5-79C5F7AAB745Q37697361-440AB708-C7A4-4090-B0B8-E5EAA69BC0E3Q38241786-7B72A4A9-E456-4523-A881-BE384A7EB5C9Q38759421-8B8F3E26-C3E0-49EA-A5D7-67B2AB041727Q39148988-32E6F3DC-49D0-41A5-9773-8C193F54B01AQ39406264-6F787C17-CBBA-4701-9209-F9104D257794Q40036187-48F6A6A0-3372-4FD2-AD2A-A6D488B681FDQ41096648-552CE8ED-B89B-48B3-9A01-DAC014BD75A0Q41170329-51A4BC3B-BE17-4B0F-8666-2F044FF6DA95Q42531323-5A871C66-7C74-4A0D-9DA1-5971B315DB41Q43899926-7D0658A4-9A4C-463B-85B5-F15E5A40772AQ46075243-972AE2CC-6B88-40D9-AE4D-1779935DECACQ47587415-EE175BF3-CCE1-489C-8B85-64EF11B026AFQ47933962-AB4D6696-351A-4BC2-A6F5-6A0633B05006Q51743706-F8F40D58-F849-43AD-8183-F70C66B0976CQ57287566-06075965-7538-4830-B9E8-9A094D1BDB05
P2860
PAKs inhibitors ameliorate schizophrenia-associated dendritic spine deterioration in vitro and in vivo during late adolescence.
description
2014 nî lūn-bûn
@nan
2014 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
PAKs inhibitors ameliorate sch ...... n vivo during late adolescence
@nl
PAKs inhibitors ameliorate sch ...... vivo during late adolescence.
@ast
PAKs inhibitors ameliorate sch ...... vivo during late adolescence.
@en
type
label
PAKs inhibitors ameliorate sch ...... n vivo during late adolescence
@nl
PAKs inhibitors ameliorate sch ...... vivo during late adolescence.
@ast
PAKs inhibitors ameliorate sch ...... vivo during late adolescence.
@en
prefLabel
PAKs inhibitors ameliorate sch ...... n vivo during late adolescence
@nl
PAKs inhibitors ameliorate sch ...... vivo during late adolescence.
@ast
PAKs inhibitors ameliorate sch ...... vivo during late adolescence.
@en
P2093
P2860
P3181
P356
P1476
PAKs inhibitors ameliorate sch ...... vivo during late adolescence.
@en
P2093
Akiko Hayashi-Takagi
Akira Sawa
Benedikt Vollrath
David A Campbell
Mayumi Nakamura
Richard L Huganir
Sergio G Duron
Yoichi Araki
P2860
P304
P3181
P356
10.1073/PNAS.1321109111
P407
P50
P577
2014-04-03T00:00:00Z